VAERS reports by lot

GSK Varicella/Shingles lot K7T79: VAERS reports

62 VAERS reports list lot K7T79 as a GSK Varicella/Shingles vaccine, received between 2021-11-12 and 2024-10-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
62
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1430%
Dermatological (non-injection-site)817%
Injection-site / Local reaction817%
Neurological715%
Musculoskeletal49%
Allergic / Anaphylactic36%
Autoimmune / Immune-mediated12%
Respiratory12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia30
Massachusetts4
Pennsylvania2
Kansas2
Delaware1
North Carolina1
Maryland1
South Carolina1
Georgia1
West Virginia1
Minnesota1
Florida1

Reports by month received

2021-113
2021-126
2022-016
2022-022
2023-1218
2024-0111
2024-029
2024-032
2024-041
2024-053
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.